| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |